Infection of human B lymphocytes with lymphocryptoviruses related to Epstein-Barr virus

Journal of Virology

Volumn 72, Issue 4, 1998, Pages 3205-3212

  Moghaddam, Amir ^b   Koch, Joachim ^b   Annis, Bethany ^b   Wang, Fred ^a,b  

^a CHANNING LABORATORY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; MEMBRANE PROTEIN; VIRUS RECEPTOR;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; BABOON; CELL IMMORTALIZATION; EPSTEIN BARR VIRUS; GENE EXPRESSION; HERPES VIRUS; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; SPECIES DIFFERENCE; VIRUS ADSORPTION; VIRUS GENOME; VIRUS INFECTION; XENOTRANSPLANTATION;

EID: 0031954297     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.4.3205-3212.1998     Document Type: Article

References (43)

1. Ablashi, D. V., P. Gerber, and J. Easton. 1979. Oncogenic herpesviruses of nonhuman primates. Comp. Immunol. Microbiol. Infect. Dis. 2:229-241.
2. Alfieri, C., J. Tanner, L. Carpentier, C. Perpete, A. Savoie, K. Paradis, G. Delage, and J. Joncas. 1996. Epstein-Barr virus transmission from a blood donor to an organ transplant recipient with recovery of the same virus strain from the recipient's blood and oropharynx. Blood 87:812-817.
3. Baskin, G. B., E. D. Roberts, D. Kuebler, L. N. Martin, B. Blauw, J. Heeney, and C. Zurcher. 1995. Squamous epithelial proliferative lesions associated with rhesus Epstein-Barr virus in simian immunodeficiency virus-infected rhesus monkeys. J. Infect. Dis. 172:535-539.
4. Beisel, C., J. Tanner, T. Matsuo, D. Thorley-Lawson, F. Kezdy, and E. Kieff. 1985. Two major outer envelope glycoproteins of Epstein-Barr virus are encoded by the same gene. J. Virol. 54:665-674.
5. Bird, A. G., S. M. McLachlan, and S. Britton. 1981. Cyclosporin A promotes spontaneous outgrowth in vitro of Epstein-Barr virus induced B-cell lines. Nature 1:300-330.
6. Burrows, J. M., R. Khanna, T. B. Sculley, M. P. Alpers, D. J. Moss, and S. R. Burrows. 1996. Identification of a naturally occurring recombinant Epstein-Barr virus isolate from New Guinea that encodes both type 1 and type 2 nuclear antigen sequences. J. Virol. 70:4829-4833.
7. Countryman, J., H. Jenson, R. Seibl, H. Wolf, and G. Miller. 1987. Polymorphic proteins encoded within BZLF1 of defective and standard Epstein-Barr viruses disrupt latency. J. Virol. 61:3672-3679.
8. Dilner, J., H. Rabin, N. Letvin, W. Henle, G. Henle, and G. Klein. 1987. Nuclear DNA-binding proteins determined by the Epstein-Barr virus related simian lymphotropic herpesviruses H. gorilla, H. pan, H. pongo and H. papio. J. Gen. Virol. 68:1587-1596.
9. Falk, L., L. Wolfe, F. Deinhardt, J. Paciga, L. Dombos, G. Klein, W. Henle, and G. Henle. 1974. Epstein-Barr virus: transformation of non-human primate lymphocytes in vitro. Int. J. Cancer. 13:363-376.
10. Falk, L. A., G. Henle, W. Henle, F. Deinhardt, and A. Schudel. 1977. Transformation of lymphocytes by Herpesvirus papio. Int. J. Cancer. 20:219-266.
11. Falk, L. A. J. 1979. A review of Herpesvirus papio, a B-lymphotropic virus of baboons related to EBV. Comp. Immunol. Microbiol. Infect. Dis. 2:257-264.
12. Feichtinger, H., S. L. Li, E. Kaaya, P. Putkonen, K. Grunewald, K. Weyrer, D. Bottiger, I. Ernberg, A. Linde, G. Biberfeld et al. 1992. A monkey model for Epstein Barr virus-associated lymphomagenesis in human acquired immunodeficiency syndrome. J. Exp. Med. 176:281-6.
13. Feichtinger, H., P. Putkonen, C. Parravicini, S. T. Li, E. E. Kaya, D. Bottiger, and P. Biberfeld. 1990. Malignant lymphomas in cynomolgus monkeys infected with simian immunodeficiency virus. Am. J. Pathol. 137:1311-1315.
14. Frank, A., W. A. Andiman, and G. Miller. 1976. Epstein-Barr virus and nonhuman primates: natural and experimental infection. Adv. Cancer Res. 23:171-201.
15. Franken, M., B. Annis, A. Ali, and F. Wang. 1995. 5′ coding and regulatory region sequence divergence with conserved function of the Epstein-Barr virus LMP2A homolog in herpesvirus papio. J. Virol. 69:8011-8019.
16. Franken, M., O. Devergne, M. Rosenzweig, B. Annis, E. Kief, and F. Wang. 1996. Comparative analysis identifies conserved tumor necrosis factor receptor-associated factor 3 binding sites in the human and simian Epstein-Barr virus oncogene LMP1. J. Virol. 70:7819-7826.
17. Fajimoto, K., K. Terato, J. Miyamoto, H. Ishiko, M. Fujisaki, F. Cho, and S. Honjo. 1990. Establishment of a B-lymphoblastoid cell line infected with Epstein-Barr-related virus from a cynomolgus monkey (Macaca fascicularis). J. Med. Primatol. 19:21-30.
18. Gerber, P., J. W. Branch, and E. N. Rosenblum. 1969. Attempts to transmit infectious mononucleosis to rhesus monkeys and marmosets and to isolate herpeslike virus. Proc. Soc. Exp. Biol. Med. 130:14-19.
19. Gerber, P., S. S. Kalter, G. Schidlovsky, W. J. Peterson, and M. D. Daniel. 1977. Biologic and antigenic characteristics of Epstein-Barr virus-related herpesviruses of chimpanzees and baboons. Int. J. Cancer. 20:448-459.
20. Gratama, J. W., M. A. Oosterveer, F. E. Zwaan, J. Lepoutre, G. Klein, and I. Ernberg. 1988. Eradication of Epstein-Barr virus by allogeneic bone marrow transplantation: implications for sites of viral latency. Proc. Natl. Acad. Sci. USA 85:8693-8696.
21. Ishida, T., and K. Yamamoto. 1987. Survey of nonhuman primates for antibodies reactive with Epstein-Barr virus (EBV) antigens and susceptibility of their lymphocytes for immortalization with EBV. J. Med. Primatol. 16: 359-371.
22. Kalter, S. S., R. L. Heberling, and J. J. Ratner. 1972. EBV antibody in sera of non-human primates. Nature 238:353-354.
23. Kief, E. 1996. Epstein-Barr virus and its replication, p. 2343-2396. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Virology. Raven Press, Philadelphia, Pa.
24. Levine, P. H., S. A. Leiseca, J. F. Hewetson, K. A. Traul, A. P. Andrese, D. J. Granlund, P. Fabrizio, and D. A. Stevens. 1980. Infection of rhesus monkeys and chimpanzees with Epstein-Barr virus. Arch. Virol. 66:341-351.
25. Li, S. L., H. Feichtinger, E. Kaaya, P. Migliorini, P. Putkonen, G. Biberfeld, J. M. Meddeldorp, P. Biberfeld, and I. Ernberg. 1993. Expression of Epstein-Barr-virus-related nuclear antigens and B-cell markers in lymphomas of SIV-immunosuppressed monkeys. Int. J. Cancer. 55:609-615.
26. Ling, P. D., and S. D. Hayward. 1995. Contribution of conserved amino acids in mediating the interaction between EBNA2 and CBF1/RBPJk. J. Virol. 69: 1944-1950.
27. Ling, P. D., J. J. Ryon, and S. D. Hayward. 1993. EBNA-2 of herpesvirus papio diverges significantly from the type A and type B EBNA-2 proteins of Epstein-Barr virus but retains an efficient transactivation domain with a conserved hydrophobic motif. J. Virol. 67:2990-3003.
28. Loeb, D. D., N. S. Sung, R. L. Pesano, C. J. Sexton, C. D. Hutchison, J. S. Pagano, and C. Hutchison. 1990. Plasmid origin of replication of herpesvirus papio: DNA sequence and enhancer function. J. Virol. 64:2876-2883.
29. Mackett, M., S. de V. Pepper, I. Hampson, H. Jenson, N. Janjua, and J. Arrand. 1997. Conservation of gp340 between Epstein-Barr virus (EBV) strains and Herpesvirus papio (HVP), abstr. 312. Presented at the 22nd International Herpesvirus Workshop.
30. Miller, G., J. C. Niederman, and D. A. Stitt 1972. Infectious mononucleosis: appearance of neutralizing antibody to Epstein-Barr virus measured by inhibition of formation of lymphoblastoid cell lines. J. Infect. Dis. 125:403-406.
31. Moghaddam, A., M. Rosenzweig, D. Lee-Parritz, B. Annis, R. P. Johnson, and F. Wang. 1997. An animal model for acute and persistent Epstein-Barr virus infection. Science 276:2030-2033.
32. 31a. Moghaddam, A., and F. Wang. Unpublished data.
33. Nemerow, G. R., R. A. Houghten, M. D. Moore, and N. R. Cooper. 1989. Identification of an epitope in the major envelope protein of Epstein-Barr virus that mediates viral binding to the B-lymphocyte EBV receptor (CR2). Cell 56:369-377.
34. Pesano, R. L., and J. S. Pagano. 1986. Herpesvirus papio contains a plasmid origin of replication that acts in cis interspecies with an Epstein-Barr virus trans-acting function. J. Virol. 60:1159-1162.
35. Rabin, H., R. H. Neubauer, R. F. Hopkins, E. K. Dzhikidze, Z. V. Shevtsova, and B. A. Lapin. 1977. Transforming activity and antigenicity of an Epstein-Barr-like virus from lymphoblastoid cell lines of baboons with lymphoid disease. Intervirology 8:240-249.
36. Rangan, S. R., L. N. Martín, B. E. Bozelka, N. Wang, and B. J. Gormus. 1986. Epstein-Barr virus-related herpesvirus from a rhesus monkey (Macaca mulatta) with malignant lymphoma. Int. J. Cancer 38:425-432.
37. Scudiero, D. A., R. H. Shoemaker, K. D. Paull, A. Monks, S. Tierney, T. H. Nofziger, M. J. Currens, D. Seniff, and M. R. Boyd. 1988. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res. 48:4827-4833.
38. Tanner, J., Y. Whang, J. Sample, A. Sears, and E. Kief. 1988. Soluble gp350/220 and deletion mutant glycoproteins block Epstein-Barr virus adsorption to lymphocytes. J. Virol. 62:4452-4464.
39. Wang, F., C. Gregory, C. Sample, M. Rowe, D. Liebowitz, R. Murray, A. Rickinson, and E. Kieff. 1990. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23. J. Virol. 64:2309-2318.
40. Wang, F., X. Li, B. Annis, and D. L. Faustman. 1995a. Tap-1 and Tap-2 gene therapy selectively restores conformationally dependent HLA class I expression in type I diabetic cells. Hum. Gene Ther. 6:1005-1017.
41. Yao, Q. Y., R. J. Tierney, D. Croom-Carter, G. M. Cooper, C. J. Ellis, M. Rowe, and A. B. Rickinson. 1996. Isolation of intertypic recombinants of Epstein-Barr virus from T-cell immunocompromised individuals. J. Virol. 70:4895-4903.
42. Yates, J. L., S. M. Camiolo, S. Ali, and A. Ying. 1996. Comparison of the EBNA-1 proteins of Epstein-Barr virus and Herpesvirus papio in sequence and function. Virology 222:1-13.
43. Young, L., C. Alfieri, K. Hennessy, H. Evans, C. O'Hara, K. C. Anderson, J. Ritz, R. S. Shapiro, A. Rickinson, E. Kieff, et al. 1989. Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. N. Engl. J. Med. 321:1080-1085.